McLellan, Jason S

Publication with MATCHING institution:

McLellan JS, Ray WC, Peeples ME (2013) Structure and function of respiratory syncytial virus surface glycoproteins.
None. [IF=None, Cited=166, 24362685].
Mazur NI, Higgins D, Nunes MC, ..., Bont LJ (2018) The respiratory syncytial virus vaccine landscape: lessons from the
graveyard and promising candidates. The Lancet Infectious Diseases. [IF=7.634, Cited=210, 29914800].
Gilman MSA, Liu C, Fung A, ..., McLellan JS (2019) Structure of the Respiratory Syncytial Virus Polymerase Complex.
Cell. [IF=8.479, Cited=75, 31495574].
Wrapp D, De Vlieger D, Corbett KS, ..., McLellan JS (2020) Structural Basis for Potent Neutralization of
Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. [IF=8.479, Cited=298, 32375025].
Fels JM, Maurer DP, Herbert AS, ..., Chandran K (2021) Protective neutralizing antibodies from human survivors of
Crimean-Congo hemorrhagic fever. Cell. [IF=8.479, Cited=29, 34077751].
Walls AC, Miranda MC, Schäfer A, ..., Veesler D (2021) Elicitation of broadly protective sarbecovirus immunity by
receptor-binding domain nanoparticle vaccines. Cell. [IF=8.479, Cited=88, 34619077].
Wang N, Rosen O, Wang L, ..., McLellan JS (2019) Structural Definition of a Neutralization-Sensitive Epitope on the
MERS-CoV S1-NTD. Cell Reports. [IF=1.738, Cited=44, 31553909].
Rutten L, Gilman MSA, Blokland S, ..., Langedijk JPM (2020) Structure-Based Design of Prefusion-Stabilized Filovirus
Glycoprotein Trimers. Cell Reports. [IF=1.738, Cited=30, 32234486].
Kramer KJ, Johnson NV, Shiakolas AR, ..., Georgiev IS (2021) Potent neutralization of SARS-CoV-2 variants of concern by
an antibody with an uncommon genetic signature and structural mode of spike recognition. Cell Reports. [IF=1.738,
Cited=16, 34592170].
Hsieh CL, Werner AP, Leist SR, ..., McLellan JS (2021) Stabilized coronavirus spike stem elicits a broadly protective
antibody. Cell Reports. [IF=1.738, Cited=41, 34710354].
Goldsmith JA, DiVenere AM, Maynard JA, McLellan JS (2022) Structural basis for non-canonical integrin engagement by
Bordetella adenylate cyclase toxin. Cell Reports. [IF=1.738, Cited=10, 35977491].
Rush SA, Brar G, Hsieh CL, ..., McLellan JS (2022) Characterization of prefusion-F-specific antibodies elicited by
natural infection with human metapneumovirus. Cell Reports. [IF=1.738, Cited=5, 36130517].
Shin OS, Monticelli SR, Hjorth CK, ..., McLellan JS (2024) Crimean-Congo hemorrhagic fever survivors elicit protective
non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38. Cell Reports. [IF=1.738, Cited=0, 39002130].
Byrne PO, McLellan JS (2022) Principles and practical applications of structure-based vaccine design. None. [IF=None,
Cited=12, 35598506].
Mukhamedova M, Wrapp D, Shen CH, ..., Mascola JR (2021) Vaccination with prefusion-stabilized respiratory syncytial
virus fusion protein induces genetically and antigenically diverse antibody responses. Immunity. [IF=5.119, Cited=21, 33823129].
Rappazzo CG, Hsieh CL, Rush SA, ..., Walker LM (2022) Potently neutralizing and protective anti-human metapneumovirus
antibodies target diverse sites on the fusion glycoprotein. Immunity. [IF=5.119, Cited=6, 35944529].
Zehner M, Alt M, Ashurov A, ..., Klein F (2023) Single-cell analysis of memory B cells from top neutralizers reveals
multiple sites of vulnerability within HCMV Trimer and Pentamer. Immunity. [IF=5.119, Cited=1, 37967532].
Osickova A, Knoblochova S, Bumba L, ..., Masin J (2023) A conserved tryptophan in the acylated segment of RTX toxins
controls their β₂ integrin-independent cell penetration. Journal of Biological Chemistry. [IF=1.122,
Cited=0, 37390987].
McLellan JS, Correia BE, Chen M, ..., Kwong PD (2011) Design and characterization of epitope-scaffold immunogens that
present the motavizumab epitope from respiratory syncytial virus. Journal of Molecular Biology. [IF=1.281, Cited=76, 21549714].
Chawla H, Jossi SE, Faustini SE, ..., Crispin M (2021) Glycosylation and Serological Reactivity of an Expression-
enhanced SARS-CoV-2 Viral Spike Mimetic. Journal of Molecular Biology. [IF=1.281, Cited=14, 34717971].
Rosen O, Chan LLY, Abiona OM, ..., Corbett KS (2018) A high-throughput inhibition assay to study MERS-CoV antibody
interactions using image cytometry. Journal of Virological Methods. [IF=0.78, Cited=8, 30468747].
Hsieh CL, McLellan JS (2022) Protein engineering responses to the COVID-19 pandemic. Current Opinion in Structural
Biology. [IF=1.4, Cited=6, 35533563].
Duc Dang A, Dinh Vu T, Hai Vu H, ..., Scharf R (2022) Safety and immunogenicity of an egg-based inactivated Newcastle
disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial
in Vietnam. Vaccine. [IF=1.264, Cited=12, 35577631].
Goodwin ML, Webster HS, Wang HY, ..., Permar SR (2020) Specificity and effector functions of non-neutralizing gB-
specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection. Virology.
[IF=0.835, Cited=5, 32838941].
Shiakolas AR, Kramer KJ, Wrapp D, ..., Georgiev IS (2021) Cross-reactive coronavirus antibodies with diverse epitope
specificities and Fc effector functions. Cell Reports Medicine. [IF=1.969, Cited=44, 34056628].
Voss WN, Mallory MA, Byrne PO, ..., Ippolito GC (2024) Hybrid immunity to SARS-CoV-2 arises from serological recall of
IgG antibodies distinctly imprinted by infection or vaccination. Cell Reports Medicine. [IF=1.969, Cited=0, 39094579].
Escobar EE, Wang S, Goswami R, ..., Brodbelt JS (2022) Analysis of Viral Spike Protein N-Glycosylation Using Ultraviolet
Photodissociation Mass Spectrometry. Analytical Chemistry. [IF=1.41, Cited=6, 35388686].
Vendeville S, Tahri A, Hu L, ..., Jonckers THM (2020) Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-
indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a
Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus. Journal of Medicinal Chemistry.
[IF=1.655, Cited=8, 32407115].
Cockerill GS, Angell RM, Bedernjak A, ..., Powell K (2021) Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory
Syncytial Virus Fusion. Journal of Medicinal Chemistry. [IF=1.655, Cited=13, 33729773].
Casalino L, Gaieb Z, Goldsmith JA, ..., Amaro RE (2020) Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike
Protein. ACS Central Science. [IF=2.363, Cited=451, 33140034].
McLellan JS, Pancera M, Carrico C, ..., Kwong PD (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing
antibody PG9. Nature. [IF=11.591, Cited=622, 22113616].
McLellan JS, Chen M, Kim A, ..., Kwong PD (2010) Structural basis of respiratory syncytial virus neutralization by
motavizumab. Nature Structural and Molecular Biology. [IF=2.542, Cited=110, 20098425].
Gilman MSA, Furmanova-Hollenstein P, Pascual G, ..., McLellan JS (2019) Transient opening of trimeric prefusion RSV F
proteins. Nature Communications. [IF=3.268, Cited=39, 31068578].
Smith TRF, Patel A, Ramos S, ..., Broderick KE (2020) Immunogenicity of a DNA vaccine candidate for COVID-19. Nature
Communications. [IF=3.268, Cited=348, 32433465].
Watanabe Y, Berndsen ZT, Raghwani J, ..., Crispin M (2020) Vulnerabilities in coronavirus glycan shields despite
extensive glycosylation. Nature Communications. [IF=3.268, Cited=196, 32461612].
Ku Z, Xie X, Davidson E, ..., An Z (2021) Molecular determinants and mechanism for antibody cocktail preventing SARS-
CoV-2 escape. Nature Communications. [IF=3.268, Cited=90, 33473140].
Kaur S, Gomez-Blanco J, Khalifa AAZ, ..., Vargas J (2021) Local computational methods to improve the interpretability
and analysis of cryo-EM maps. Nature Communications. [IF=3.268, Cited=27, 33623015].
Ku Z, Xie X, Davidson E, ..., An Z (2021) Author Correction: Molecular determinants and mechanism for antibody cocktail
preventing SARS-CoV-2 escape. Nature Communications. [IF=3.268, Cited=6, 34210985].
Li T, Xue W, Zheng Q, ..., Xia N (2021) Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist
circulating variants. Nature Communications. [IF=3.268, Cited=30, 34580306].
Hsieh CL, Rush SA, Palomo C, ..., McLellan JS (2022) Structure-based design of prefusion-stabilized human
metapneumovirus fusion proteins. Nature Communications. [IF=3.268, Cited=14, 35288548].
Byrne PO, Fisher BE, Ambrozak DR, ..., Loomis RJ (2023) Structural basis for antibody recognition of vulnerable epitopes
on Nipah virus F protein. Nature Communications. [IF=3.268, Cited=3, 36932063].
Hutchinson GB, Abiona OM, Ziwawo CT, ..., Corbett-Helaire KS (2023) Nanoparticle display of prefusion coronavirus spike
elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera. Nature Communications.
[IF=3.268, Cited=3, 37794071].
Hsieh CL, Leist SR, Miller EH, ..., McLellan JS (2024) Prefusion-stabilized SARS-CoV-2 S2-only antigen provides
protection against SARS-CoV-2 challenge. Nature Communications. [IF=3.268, Cited=0, 38378768].
Gidwani SV, Brahmbhatt D, Zomback A, ..., Yondola MA (2024) Engineered dityrosine-bonding of the RSV prefusion F protein
imparts stability and potency advantages. Nature Communications. [IF=3.268, Cited=0, 38485927].
Langedijk JPM, Cox F, Johnson NV, ..., Bakkers MJG (2024) Universal paramyxovirus vaccine design by stabilizing regions
involved in structural transformation of the fusion protein. Nature Communications. [IF=3.268, Cited=0, 38821950].
Johnson NV, van Scherpenzeel RC, Bakkers MJG, ..., McLellan JS (2024) Structural basis for potent neutralization of
human respirovirus type 3 by protective single-domain camelid antibodies. Nature Communications. [IF=3.268, Cited=0, 38937429].
Sztain T, Ahn SH, Bogetti AT, ..., Amaro RE (2021) A glycan gate controls opening of the SARS-CoV-2 spike protein.
Nature Chemistry. [IF=3.667, Cited=169, 34413500].
Battles MB, McLellan JS (2019) Respiratory syncytial virus entry and how to block it. Nature Reviews Microbiology.
[IF=6.979, Cited=118, 30723301].
Corbett KS, Edwards DK, Leist SR, ..., Graham BS (2020) SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen
preparedness. Nature. [IF=11.591, Cited=795, 32756549].
Liang CY, Raju S, Liu Z, ..., Diamond MS (2024) Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.
Nature. [IF=11.591, Cited=0, 38749479].
Shiakolas AR, Kramer KJ, Johnson NV, ..., Georgiev IS (2022) Efficient discovery of SARS-CoV-2-neutralizing antibodies
via B cell receptor sequencing and ligand blocking. Nature Biotechnology. [IF=8.861, Cited=16, 35241839].
Costello SM, Shoemaker SR, Hobbs H, ..., Marqusee S (2022) The SARS-CoV-2 spike reversibly samples an open-trimer
conformation exposing novel epitopes. Nature Structural and Molecular Biology. [IF=2.542, Cited=55, 35236990].
Schaub JM, Chou CW, Kuo HC, ..., Finkelstein IJ (2021) Expression and characterization of SARS-CoV-2 spike proteins.
None. [IF=None, Cited=24, 34611365].
Kirchdoerfer RN, Wang N, Pallesen J, ..., Ward AB (2018) Stabilized coronavirus spikes are resistant to conformational
changes induced by receptor recognition or proteolysis. Scientific Reports. [IF=1.312, Cited=286, 30356097].
Kirchdoerfer RN, Wang N, Pallesen J, ..., Ward AB (2018) Publisher Correction: Stabilized coronavirus spikes are
resistant to conformational changes induced by receptor recognition or proteolysis. Scientific Reports. [IF=1.312,
Cited=8, 30531867].
Yu X, Abeywickrema P, Bonneux B, ..., Jin Z (2023) Structural and mechanistic insights into the inhibition of
respiratory syncytial virus polymerase by a non-nucleoside inhibitor. Communications Biology. [IF=1.359, Cited=2, 37865687].
Goike J, Hsieh CL, Horton AP, ..., Gollihar JD (2023) SARS-COV-2 Omicron variants conformationally escape a rare
quaternary antibody binding mode. Communications Biology. [IF=1.359, Cited=2, 38082099].
Andreano E, Piccini G, Licastro D, ..., Rappuoli R (2021) SARS-CoV-2 escape from a highly neutralizing COVID-19
convalescent plasma. Proceedings of the National Academy of Sciences of the United States of America. [IF=2.765,
Cited=284, 34417349].
Banerjee A, Huang J, Rush SA, ..., Mousa JJ (2022) Structural basis for ultrapotent antibody-mediated neutralization of
human metapneumovirus. Proceedings of the National Academy of Sciences of the United States of America. [IF=2.765,
Cited=5, 35696580].
Li L, Wen Y, Wrapp D, ..., An Z (2022) A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver
injury in mice. Antibody Therapeutics. [IF=0.667, Cited=1, 36683763].
Simões EAF, Forleo-Neto E, Geba GP, ..., Sivapalasingam S (2021) Suptavumab for the Prevention of Medically Attended
Respiratory Syncytial Virus Infection in Preterm Infants. Clinical Infectious Diseases. [IF=2.495, Cited=47, 32897368].
Wrapp D, Wang N, Corbett KS, ..., McLellan JS (2020) Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion
Conformation. None. [IF=None, Cited=12, 32511295].
Watanabe Y, Allen JD, Wrapp D, ..., Crispin M (2020) Site-specific analysis of the SARS-CoV-2 glycan shield. None.
[IF=None, Cited=0, 32511336].
Wec AZ, Wrapp D, Herbert AS, ..., Walker LM (2020) Broad sarbecovirus neutralizing antibodies define a key site of
vulnerability on the SARS-CoV-2 spike protein. None. [IF=None, Cited=0, 32511337].
Hsieh CL, Goldsmith JA, Schaub JM, ..., McLellan JS (2020) Structure-based Design of Prefusion-stabilized SARS-CoV-2
Spikes. None. [IF=None, Cited=0, 32577660].
Corbett KS, Edwards D, Leist SR, ..., Graham BS (2020) SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen
Preparedness. None. [IF=None, Cited=0, 32577634].
Casalino L, Gaieb Z, Goldsmith JA, ..., Amaro RE (2020) Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike
Protein. None. [IF=None, Cited=0, 32577644].
Melero R, Sorzano COS, Foster B, ..., Carazo JM (2020) Continuous flexibility analysis of SARS-CoV-2 Spike prefusion
structures. None. [IF=None, Cited=0, 32676604].
Long SW, Olsen RJ, Christensen PA, ..., Musser JM (2020) Molecular Architecture of Early Dissemination and Massive
Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. None. [IF=None, Cited=0, 33024977].
Rappazzo CG, Tse LV, Kaku CI, ..., Walker LM (2020) An Engineered Antibody with Broad Protective Efficacy in Murine
Models of SARS and COVID-19. None. [IF=None, Cited=3, 33236009].
Andreano E, Piccini G, Licastro D, ..., Rappuoli R (2020) SARS-CoV-2 escape in vitro from a highly neutralizing
COVID-19 convalescent plasma. None. [IF=None, Cited=1, 33398278].
Wang X, Du Z, Johnson KE, ..., Meyers LA (2021) The impacts of COVID-19 vaccine timing, number of doses, and risk
prioritization on mortality in the US. None. [IF=None, Cited=1, 33501453].
Sztain T, Ahn SH, Bogetti AT, ..., Amaro RE (2021) A glycan gate controls opening of the SARS-CoV-2 spike protein. None.
[IF=None, Cited=0, 33619492].
Walls AC, Miranda MC, Pham MN, ..., Veesler D (2021) Elicitation of broadly protective sarbecovirus immunity by
receptor-binding domain nanoparticle vaccines. None. [IF=None, Cited=0, 33758839].
Goike J, Hsieh CL, Horton A, ..., Gollihar JD (2021) Synthetic repertoires derived from convalescent COVID-19 patients
enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality. None. [IF=None,
Cited=1, 33851158].
Johnson NV, Wall SC, Kramer KJ, ..., Georgiev IS (2024) Discovery and Characterization of a Pan-betacoronavirus
S2-binding antibody. None. [IF=None, Cited=0, 38293237].
Shin OS, Monticelli SR, Hjorth CK, ..., McLellan JS (2024) Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective
Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38. None. [IF=None, Cited=0, 38496658].
McFadden E, Monticelli SR, Wang A, ..., McLellan JS (2024) Engineering, structure, and immunogenicity of a Crimean-Congo
hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex. None. [IF=None, Cited=0, 38659837].
Pahmeier F, Monticelli SR, Feng X, ..., Harris E (2024) Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38
limit vascular leak and viral spread. None. [IF=None, Cited=0, 38826290].
Melero R, Sorzano COS, Foster B, ..., Carazo JM (2020) Continuous flexibility analysis of SARS-CoV-2 spike prefusion
structures. IUCrJ. [IF=1.22, Cited=28, 33063791].
Cable J, Graham BS, Koup RA, ..., Bekker LG (2023) Progress in vaccine development for infectious diseases-a Keystone
Symposia report. Annals of the New York Academy of Sciences. [IF=1.878, Cited=1, 37020354].
Wrapp D, Ye X, Ku Z, ..., McLellan JS (2022) Structural basis for HCMV Pentamer recognition by neuropilin 2 and
neutralizing antibodies. Science advances. [IF=2.861, Cited=7, 35275718].
Shaban NM, Yan R, Shi K, ..., Harris RS (2022) Cryo-EM structure of the EBV ribonucleotide reductase BORF2 and mechanism
of APOBEC3B inhibition. Science advances. [IF=2.861, Cited=12, 35476445].
Azoitei ML, Correia BE, Ban YEA, ..., Schief WR (2011) Computation-guided backbone grafting of a discontinuous motif
onto a protein scaffold. Science. [IF=7.729, Cited=143, 22021856].
McLellan JS, Chen M, Leung S, ..., Graham BS (2013) Structure of RSV fusion glycoprotein trimer bound to a prefusion-
specific neutralizing antibody. Science. [IF=7.729, Cited=464, 23618766].
McLellan JS, Chen M, Joyce MG, ..., Kwong PD (2013) Structure-based design of a fusion glycoprotein vaccine for
respiratory syncytial virus. Science. [IF=7.729, Cited=557, 24179220].
Crank MC, Ruckwardt TJ, Chen M, ..., Graham BS (2019) A proof of concept for structure-based vaccine design targeting
RSV in humans. Science. [IF=7.729, Cited=142, 31371616].
Wrapp D, Wang N, Corbett KS, ..., McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion
conformation. Science. [IF=7.729, Cited=1000, 32075877].
Watanabe Y, Allen JD, Wrapp D, ..., Crispin M (2020) Site-specific glycan analysis of the SARS-CoV-2 spike. Science.
[IF=7.729, Cited=857, 32366695].
Wec AZ, Wrapp D, Herbert AS, ..., Walker LM (2020) Broad neutralization of SARS-related viruses by human monoclonal
antibodies. Science. [IF=7.729, Cited=350, 32540900].
Rappazzo CG, Tse LV, Kaku CI, ..., Walker LM (2021) Broad and potent activity against SARS-like viruses by an engineered
human monoclonal antibody. Science. [IF=7.729, Cited=167, 33495307].
Voss WN, Hou YJ, Johnson NV, ..., Ippolito GC (2021) Prevalent, protective, and convergent IgG recognition of SARS-CoV-2
non-RBD spike epitopes. Science. [IF=7.729, Cited=143, 33947773].
Mishra AK, Hellert J, Freitas N, ..., Rey FA (2021) Structural basis of synergistic neutralization of Crimean-Congo
hemorrhagic fever virus by human antibodies. Science. [IF=7.729, Cited=15, 34793197].
Sakharkar M, Rappazzo CG, Wieland-Alter WF, ..., Walker LM (2021) Prolonged evolution of the human B cell response to
SARS-CoV-2 infection. Science immunology. [IF=3.246, Cited=105, 33622975].
Kaplonek P, Wang C, Bartsch Y, ..., Alter G (2021) Early cross-coronavirus reactive signatures of humoral immunity
against COVID-19. Science immunology. [IF=3.246, Cited=49, 34652962].
Ngwuta JO, Chen M, Modjarrad K, ..., Graham BS (2015) Prefusion F-specific antibodies determine the magnitude of RSV
neutralizing activity in human sera. Science Translational Medicine. [IF=2.778, Cited=219, 26468324].
Jones BE, Brown-Augsburger PL, Corbett KS, ..., Falconer E (2021) The neutralizing antibody, LY-CoV555, protects against
SARS-CoV-2 infection in nonhuman primates. Science Translational Medicine. [IF=2.778, Cited=232, 33820835].
Phung E, Chang LA, Mukhamedova M, ..., Ruckwardt TJ (2022) Elicitation of pneumovirus-specific B cell responses by a
prefusion-stabilized respiratory syncytial virus F subunit vaccine. Science Translational Medicine. [IF=2.778, Cited=3, 35731888].
Tse LV, Hou YJ, McFadden E, ..., Baric RS (2023) A MERS-CoV antibody neutralizes a pre-emerging group 2c bat
coronavirus. Science Translational Medicine. [IF=2.778, Cited=2, 37756379].
Nelson CS, Jenks JA, Pardi N, ..., Permar SR (2020) Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA
Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization.
Journal of Virology. [IF=1.075, Cited=26, 32051265].
Liang B, Ngwuta JO, Surman S, ..., Munir S (2017) Improved Prefusion Stability, Optimized Codon Usage, and Augmented
Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine
Candidate. Journal of Virology. [IF=1.075, Cited=23, 28539444].
Hansman GS, Biertümpfel C, Georgiev I, ..., Kwong PD (2011) Crystal structures of GII.10 and GII.12 norovirus protruding
domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. Journal of
Virology. [IF=1.075, Cited=87, 21525337].
McLellan JS, Yang Y, Graham BS, Kwong PD (2011) Structure of respiratory syncytial virus fusion glycoprotein in the
postfusion conformation reveals preservation of neutralizing epitopes. Journal of Virology. [IF=1.075, Cited=255, 21613394].
Hicks SN, Chaiwatpongsakorn S, Costello HM, ..., Peeples ME (2018) Five Residues in the Apical Loop of the Respiratory
Syncytial Virus Fusion Protein F₂ Subunit Are Critical for Its Fusion Activity. Journal of Virology.
[IF=1.075, Cited=7, 29743373].
Doria-Rose NA, Georgiev I, O'Dell S, ..., Mascola JR (2012) A short segment of the HIV-1 gp120 V1/V2 region is a major
determinant of resistance to V1/V2 neutralizing antibodies. Journal of Virology. [IF=1.075, Cited=61, 22623764].
Wrapp D, McLellan JS (2019) The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus
Spike Protein in the Prefusion Conformation. Journal of Virology. [IF=1.075, Cited=39, 31534041].
Pancera M, McLellan JS, Wu X, ..., Kwong PD (2010) Crystal structure of PG16 and chimeric dissection with somatically
related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.
Journal of Virology. [IF=1.075, Cited=164, 20538861].
Liang B, Ngwuta JO, Herbert R, ..., Munir S (2016) Packaging and Prefusion Stabilization Separately and Additively
Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion
Protein Expressed by a Parainfluenza Virus Vector. Journal of Virology. [IF=1.075, Cited=23, 27581977].
Liang B, Surman S, Amaro-Carambot E, ..., Munir S (2015) Enhanced Neutralizing Antibody Response Induced by Respiratory
Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate. Journal of Virology. [IF=1.075, Cited=51, 26157122].
McLellan JS, Chen M, Chang JS, ..., Kwong PD (2010) Structure of a major antigenic site on the respiratory syncytial
virus fusion glycoprotein in complex with neutralizing antibody 101F. Journal of Virology. [IF=1.075, Cited=78, 20881049].
Mishra AK, Moyer CL, Abelson DM, ..., McLellan JS (2020) Structure and Characterization of Crimean-Congo Hemorrhagic
Fever Virus GP38. Journal of Virology. [IF=1.075, Cited=21, 31996434].
Acharya P, Tolbert WD, Gohain N, ..., Pazgier M (2014) Structural definition of an antibody-dependent cellular
cytotoxicity response implicated in reduced risk for HIV-1 infection. Journal of Virology. [IF=1.075, Cited=85, 25165110].
Hansman GS, Shahzad-Ul-Hussan S, McLellan JS, ..., Kwong PD (2011) Structural basis for norovirus inhibition and fucose
mimicry by citrate. Journal of Virology. [IF=1.075, Cited=47, 22031945].
Johnson TR, McLellan JS, Graham BS (2011) Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN
to activate ERK1 and ERK2. Journal of Virology. [IF=1.075, Cited=56, 22090124].
Hansman GS, Taylor DW, McLellan JS, ..., Kwong PD (2012) Structural basis for broad detection of genogroup II
noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. Journal of Virology.
[IF=1.075, Cited=61, 22278249].
Goldsmith JA, Dewar V, Hermand P, ..., McLellan JS (2023) Structural Basis for Binding of Neutralizing Antibodies to
Clostridioides difficile Binary Toxin. Journal of Bacteriology. [IF=0.898, Cited=1, 36951574].
McCool RS, Musayev M, Bush SM, ..., McLellan JS (2023) Vaccination with prefusion-stabilized respiratory syncytial virus
fusion protein elicits antibodies targeting a membrane-proximal epitope. Journal of Virology. [IF=1.075, Cited=0, 37737588].
Byrne PO, Blade EG, Fisher BE, ..., McLellan JS (2024) Prefusion stabilization of the Hendra and Langya virus F
proteins. Journal of Virology. [IF=1.075, Cited=0, 38214525].
Stephens LM, Ross KA, McLellan JS, ..., Varga SM (2022) Long-Lasting Protection Induced by a Polyanhydride Nanovaccine
against Respiratory Syncytial Virus in an Outbred Mouse Model. Journal of Virology. [IF=1.075, Cited=2, 36314826].
Haslwanter D, Dieterle ME, Wec AZ, ..., Jangra RK (2021) A Combination of Receptor-Binding Domain and N-Terminal Domain
Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants. mBio. [IF=1.357,
Cited=26, 34607456].
Long SW, Olsen RJ, Christensen PA, ..., Musser JM (2020) Molecular Architecture of Early Dissemination and Massive
Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. mBio. [IF=1.357, Cited=80, 33127862].
McNamara RP, Maron JS, Boucau J, ..., Alter G (2023) Anamnestic humoral correlates of immunity across SARS-CoV-2
variants of concern. mBio. [IF=1.357, Cited=2, 37535402].
Ballegeer M, van Scherpenzeel RC, Delgado T, ..., Saelens X (2023) A neutralizing single-domain antibody that targets
the trimer interface of the human metapneumovirus fusion protein. mBio. [IF=1.357, Cited=0, 38117059].
Graham BS, Gilman MSA, McLellan JS (2019) Structure-Based Vaccine Antigen Design. Annual Review of Medicine. [IF=3.155,
Cited=101, 30691364].
Stewart-Jones GBE, Thomas PV, Chen M, ..., Kwong PD (2015) A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein
Vaccine for Respiratory Syncytial Virus. PLoS ONE. [IF=1.253, Cited=32, 26098893].
Jones HG, Battles MB, Lin CC, ..., McLellan JS (2019) Alternative conformations of a major antigenic site on RSV F. PLoS
Pathogens. [IF=1.423, Cited=20, 31306469].
Ye X, Su H, Wrapp D, ..., An Z (2020) Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody
neutralizing HCMV at a post-attachment step. PLoS Pathogens. [IF=1.423, Cited=11, 32745149].
Goldsmith JA, DiVenere AM, Maynard JA, McLellan JS (2021) Structural basis for antibody binding to adenylate cyclase
toxin reveals RTX linkers as neutralization-sensitive epitopes. PLoS Pathogens. [IF=1.423, Cited=9, 34547035].
Cressey TN, Shareef AM, Kleiner VA, ..., Fearns R (2022) Distinctive features of the respiratory syncytial virus priming
loop compared to other non-segmented negative strand RNA viruses. PLoS Pathogens. [IF=1.423, Cited=4, 35731802].
Jenks JA, Amin S, Sponholtz MR, ..., Permar SR (2023) A single, improbable B cell receptor mutation confers potent
neutralization against cytomegalovirus. PLoS Pathogens. [IF=1.423, Cited=0, 36662906].
Joyce MG, Bao A, Chen M, ..., Kwong PD (2019) Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion
Glycoprotein From Respiratory Syncytial Virus Subtype B. Pathogens and Immunity. [IF=1.129, Cited=15, 31893251].
Loomis RJ, Stewart-Jones GBE, Tsybovsky Y, ..., Graham BS (2020) Structure-Based Design of Nipah Virus Vaccines: A
Generalizable Approach to Paramyxovirus Immunogen Development. Frontiers in Immunology. [IF=1.49, Cited=28, 32595632].
Stephens LM, Ross KA, Waldstein KA, ..., Varga SM (2021) Prefusion F-Based Polyanhydride Nanovaccine Induces Both
Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus. Journal of
Immunology. [IF=0.939, Cited=7, 33827894].
Silva RP, Huang Y, Nguyen AW, ..., Maynard JA (2023) Identification of a conserved S2 epitope present on spike proteins
from all highly pathogenic coronaviruses. eLife. [IF=1.743, Cited=26, 36942851].

Publication with MISMATCHING institution:

Graham BS, Modjarrad K, McLellan JS (2015) Novel antigens for RSV vaccines. None. [IF=None, Cited=75, 26070108].
McLellan JS (2015) Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. Current Opinion in
Virology. [IF=1.27, Cited=64, 25819327].
Goodwin E, Gilman MSA, Wrapp D, ..., Walker LM (2018) Infants Infected with Respiratory Syncytial Virus Generate Potent
Neutralizing Antibodies that Lack Somatic Hypermutation. Immunity. [IF=5.119, Cited=85, 29396163].
Hervé PL, Deloizy C, Descamps D, ..., Riffault S (2016) RSV N-nanorings fused to palivizumab-targeted neutralizing
epitope as a nanoparticle RSV vaccine. Nanomedicine: Nanotechnology, Biology, and Medicine. [IF=0.914, Cited=19, 27553073].
Rossey I, McLellan JS, Saelens X, Schepens B (2017) Clinical Potential of Prefusion RSV F-specific Antibodies. Trends in
Microbiology. [IF=3.2, Cited=25, 29054341].
Melero JA, Mas V, McLellan JS (2016) Structural, antigenic and immunogenic features of respiratory syncytial virus
glycoproteins relevant for vaccine development. Vaccine. [IF=1.264, Cited=41, 27692522].
McLellan JS, Prieto PM, Marcos S, Burns SA (2006) Effects of interactions among wave aberrations on optical image
quality. Vision Research. [IF=0.963, Cited=31, 16697435].
McLellan JS, Eskew RT (2000) ON and OFF S-cone pathways have different long-wave cone inputs. Vision Research.
[IF=0.963, Cited=28, 10915885].
Zhang F, McLellan JS, Ayala AM, ..., Linhardt RJ (2007) Kinetic and structural studies on interactions between heparin
or heparan sulfate and proteins of the hedgehog signaling pathway. Biochemistry. [IF=0.753, Cited=52, 17348690].
Andreana PR, McLellan JS, Chen Y, Wang PG (2002) Synthesis of 2,6-dideoxysugars via ring-closing olefinic metathesis.
Organic Letters. [IF=1.091, Cited=10, 12599481].
McLellan JS, Zheng X, Hauk G, ..., Leahy DJ (2008) The mode of Hedgehog binding to Ihog homologues is not conserved
across different phyla. Nature. [IF=11.591, Cited=111, 18794898].
Kirchdoerfer RN, Cottrell CA, Wang N, ..., Ward AB (2016) Pre-fusion structure of a human coronavirus spike protein.
Nature. [IF=11.591, Cited=435, 26935699].
Battles MB, Langedijk JP, Furmanova-Hollenstein P, ..., McLellan JS (2015) Molecular mechanism of respiratory syncytial
virus fusion inhibitors. Nature Chemical Biology. [IF=2.623, Cited=77, 26641933].
Meyer PA, Socias S, Key J, ..., Sliz P (2016) Data publication with the structural biology data grid supports live
analysis. Nature Communications. [IF=3.268, Cited=76, 26947396].
Rossey I, Gilman MSA, Kabeche SC, ..., Saelens X (2017) Potent single-domain antibodies that arrest respiratory
syncytial virus fusion protein in its prefusion state. Nature Communications. [IF=3.268, Cited=43, 28194013].
Krarup A, Truan D, Furmanova-Hollenstein P, ..., Langedijk JPM (2015) A highly stable prefusion RSV F vaccine derived
from structural analysis of the fusion mechanism. Nature Communications. [IF=3.268, Cited=186, 26333350].
Cao L, Diedrich JK, Ma Y, ..., Paulson JC (2018) Global site-specific analysis of glycoprotein N-glycan processing.
None. [IF=None, Cited=37, 29725121].
Roymans D, Alnajjar SS, Battles MB, ..., Koul A (2017) Therapeutic efficacy of a respiratory syncytial virus fusion
inhibitor. Nature Communications. [IF=3.268, Cited=40, 28761099].
Battles MB, Más V, Olmedillas E, ..., McLellan JS (2017) Structure and immunogenicity of pre-fusion-stabilized human
metapneumovirus F glycoprotein. Nature Communications. [IF=3.268, Cited=60, 29142300].
Tian D, Battles MB, Moin SM, ..., Graham BS (2017) Structural basis of respiratory syncytial virus subtype-dependent
neutralization by an antibody targeting the fusion glycoprotein. Nature Communications. [IF=3.268, Cited=35, 29187732].
Chang MR, Tomasovic L, Kuzmina NA, ..., Marasco WA (2022) IgG-like bispecific antibodies with potent and synergistic
neutralization against circulating SARS-CoV-2 variants of concern. Nature Communications. [IF=3.268, Cited=5, 36192374].
Grigoryan L, Lee A, Walls AC, ..., Pulendran B (2022) Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant
adjuvants induces durable protection in mice. npj Vaccines. [IF=1.634, Cited=21, 35606518].
Arunachalam PS, Walls AC, Golden N, ..., Pulendran B (2021) Adjuvanting a subunit COVID-19 vaccine to induce protective
immunity. Nature. [IF=11.591, Cited=181, 33873199].
McLellan JS, Yao S, Zheng X, ..., Leahy DJ (2006) Structure of a heparin-dependent complex of Hedgehog and Ihog.
Proceedings of the National Academy of Sciences of the United States of America. [IF=2.765, Cited=61, 17077139].
Pallesen J, Wang N, Corbett KS, ..., McLellan JS (2017) Immunogenicity and structures of a rationally designed prefusion
MERS-CoV spike antigen. Proceedings of the National Academy of Sciences of the United States of America. [IF=2.765,
Cited=624, 28807998].
Kaplonek P, Wang C, Bartsch Y, ..., Alter G (2021) Early cross-coronavirus reactive signatures of protective humoral
immunity against COVID-19. None. [IF=None, Cited=1, 34013263].
Jones HG, Wrapp D, Gilman MSA, ..., McLellan JS (2019) Iterative screen optimization maximizes the efficiency of
macromolecular crystallization. Acta Crystallographica Section F:Structural Biology Communications. [IF=0.303, Cited=3, 30713164].
Misasi J, Gilman MSA, Kanekiyo M, ..., McLellan JS (2016) Structural and molecular basis for Ebola virus neutralization
by protective human antibodies. Science. [IF=7.729, Cited=117, 26917592].
Hsieh CL, Goldsmith JA, Schaub JM, ..., McLellan JS (2020) Structure-based design of prefusion-stabilized SARS-CoV-2
spikes. Science. [IF=7.729, Cited=608, 32703906].
Gilman MSA, Castellanos CA, Chen M, ..., Walker LM (2016) Rapid profiling of RSV antibody repertoires from the memory B
cells of naturally infected adult donors. Science immunology. [IF=3.246, Cited=107, 28111638].
Zhu Q, McLellan JS, Kallewaard NL, ..., Suzich JA (2017) A highly potent extended half-life antibody as a potential RSV
vaccine surrogate for all infants. Science Translational Medicine. [IF=2.778, Cited=111, 28469033].
Zhao M, Zheng ZZ, Chen M, ..., Xia NS (2017) Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal
Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab. Journal of Virology.
[IF=1.075, Cited=14, 28539438].
Leemans A, De Schryver M, Van der Gucht W, ..., Delputte P (2017) Antibody-Induced Internalization of the Human
Respiratory Syncytial Virus Fusion Protein. Journal of Virology. [IF=1.075, Cited=10, 28468888].
van Doremalen N, Miazgowicz KL, Milne-Price S, ..., Munster VJ (2014) Host species restriction of Middle East
respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4. Journal of Virology. [IF=1.075,
Cited=150, 24899185].
Wang L, Shi W, Chappell JD, ..., Graham BS (2018) Importance of Neutralizing Monoclonal Antibodies Targeting Multiple
Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
Journal of Virology. [IF=1.075, Cited=108, 29514901].
Ha S, Li F, Troutman MC, ..., Fu TM (2017) Neutralization of Diverse Human Cytomegalovirus Strains Conferred by
Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex. Journal of Virology. [IF=1.075, Cited=43, 28077654].
Li Z, Wang D, Gu Y, ..., Xia N (2017) Crystal Structures of Two Immune Complexes Identify Determinants for Viral
Infectivity and Type-Specific Neutralization of Human Papillomavirus. mBio. [IF=1.357, Cited=14, 28951471].
DiVenere AM, Amengor D, Silva RP, ..., Maynard JA (2022) Blockade of the Adenylate Cyclase Toxin Synergizes with
Opsonizing Antibodies to Protect Mice against Bordetella pertussis. mBio. [IF=1.357, Cited=3, 35920558].
Choi JH, Woo HM, Lee TY, ..., Lee H (2020) Characterization of a human monoclonal antibody generated from a B-cell
specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus. PLoS ONE. [IF=1.253,
Cited=6, 32384116].
Falzarano D, de Wit E, Feldmann F, ..., Munster VJ (2014) Infection with MERS-CoV causes lethal pneumonia in the common
marmoset. PLoS Pathogens. [IF=1.423, Cited=157, 25144235].
Gilman MSA, Moin SM, Mas V, ..., McLellan JS (2015) Characterization of a Prefusion-Specific Antibody That Recognizes a
Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein. PLoS Pathogens. [IF=1.423, Cited=83, 26161532].
Más V, Rodriguez L, Olmedillas E, ..., McLellan JS (2016) Engineering, Structure and Immunogenicity of the Human
Metapneumovirus F Protein in the Postfusion Conformation. PLoS Pathogens. [IF=1.423, Cited=29, 27611367].
Jones HG, Ritschel T, Pascual G, ..., McLellan JS (2018) Structural basis for recognition of the central conserved
region of RSV G by neutralizing human antibodies. PLoS Pathogens. [IF=1.423, Cited=38, 29509814].
Olmedillas E, Cano O, Martínez I, ..., Más V (2018) Chimeric Pneumoviridae fusion proteins as immunogens to
induce cross-neutralizing antibody responses. EMBO Molecular Medicine. [IF=1.957, Cited=7, 29217660].
Hwang JY, Holland JE, Valenteros KB, ..., Usherwood EJ (2019) Dissociating STAT4 and STAT5 Signaling Inhibitory
Functions of SOCS3: Effects on CD8 T Cell Responses. ImmunoHorizons. [IF=0.484, Cited=0, 31748225].
McLellan JS, Marcos S, Burns SA (2001) Age-related changes in monochromatic wave aberrations of the human eye.
Investigative Ophthalmology and Visual Science. [IF=1.361, Cited=0, 11328756].

McLellan, Jason S

Publication with MATCHING institution:

Publication with MISMATCHING institution:

Publication with MISSING institution: